# Taxane Acute Pain Syndrome (TAPS) in Patients Receiving Taxane Chemotherapy for Breast or Prostate Cancer

> **NCT02362087** · — · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 75 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **OTHER:** Quality of life and brief pain inventory

## Key facts

- **NCT ID:** NCT02362087
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02362087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02362087, "Taxane Acute Pain Syndrome (TAPS) in Patients Receiving Taxane Chemotherapy for Breast or Prostate Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02362087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*